Home - Products - Microbiology/Virology - HIV - gp120-α4β7 binding inhibitor 11

gp120-α4β7 binding inhibitor 11

CAS No. 869474-87-3

gp120-α4β7 binding inhibitor 11( —— )

Catalog No. M35947 CAS No. 869474-87-3

gp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 193 In Stock
5MG 179 In Stock
10MG 263 In Stock
25MG 392 In Stock
50MG 542 In Stock
100MG 728 In Stock
200MG 986 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    gp120-α4β7 binding inhibitor 11
  • Note
    Research use only, not for human use.
  • Brief Description
    gp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM).
  • Description
    gp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV Protease
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    869474-87-3
  • Formula Weight
    413.51
  • Molecular Formula
    C26H27N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(NC1=C(C(NCC2=CC=C(C)C=C2)=O)C=CC=C1)=O)N3CC=4C(CC3)=CC=CC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bevirimat

    Bevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.

  • Tripterifordin

    Tripterifordin shows anti-HIV replication activity in H9 lymphocyte cells with an EC50 of 1 microgram/ml.

  • HIV-1 inhibitor 18A

    HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.